Pace quickens for Chr Hansen sale

The sale of Chr Hansen's ingredients arm gains pace with reports
suggesting the unit could fetch nearly €1 billion ($1.31 billion),
writes Lindsey Partos.

Citing an un-attributable source, the Danish daily newspaper Jyllands-Posten​ said that following initial interest from about 20 to 25 investment funds and firms in the Danish firm's ingredients business, now there are about 7 to 8 bidders left in the running.

The Financial Times​ quotes the Danish paper as suggesting the unit is likely to end up in foreign hands after fellow ingredients and enzymes firms Danisco and Novozymes opt out of the purchase.

Number one cultures supplier Chr. Hansen came up for sale in November last year after its major stakeholder decided to pull away from the ingredients slice of the company to focus on the pharmaceutical unit.

The move evolved out of discussions over the past three years to separate the Danish group into two independent listed companies, an ingredient and an allergy vaccine company.

But the primary shareholder in Chr Hansen, the Lundbeck Foundation that has its roots in the pharmaceutical business, informed the group's board that it does not wish to be a long-term strategic shareholder in the ingredients company.

The ingredients operations of Chr. Hansen include cultures, enzymes, colours - where it is the number one natural colour supplier - flavours, seasonings and sweeteners. Industry players with the clout to acquire Chr Hansen may well meet with competition concerns. As such, observers could suspect the group will be broken up into units.

But the CEO of Chr Hansen, Erik Soerensen told at the time that this is definitely not the case: "The ingredients business will not be split up, it is all or nothing."

At €450 million last year the ingredients unit contributed the majority of revenue to the group, compared to the €141 million contribution from the pharmaceutical unit, ALK-Abello, that focuses on allergy treatment and asthma prevention products.

Industry reports rumour that DSM, the Dutch chemicals group, has entered the frame to bid for the ingredients unit. Irish food group Kerry, could be another strategic bidder.

Related news

Show more

Related products

Alternative dairy innovation

Alternative dairy innovation

Lallemand Bio-Ingredients | 21-Oct-2022 | Technical / White Paper

Lallemand Bio-Ingredients offers an elaborate portfolio of specialty ingredients to help address the many challenges surrounding alternative dairy products.

Enhancing freeze-drying survival rate

Enhancing freeze-drying survival rate

Angel Yeast – Fermentation Nutrition | 02-Sep-2022 | Technical / White Paper

Angel Yeast has concluded that nucleic acids in yeast extract have significant positive effect on improving the biomass and survival rate of Lactobacillus...

Writing a brief for an ingredient supplier

Writing a brief for an ingredient supplier

BIOSPRINGER, natural Yeast ingredients | 04-Feb-2022 | Application Note

Finding an ingredient supplier can be time consuming and requires technical skills to consider the many criteria. At Biospringer, we have developed, in...

Related suppliers

Follow us


View more